Article
Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer.
Oncogene - 19 May 2005
Jones Laundette P, Li Minglin, Halama Ewa D, Ma Yongxian, Lubet Ronald, Grubbs Clinton J, Deng Chu-Xia, Rosen Eliot M, Furth Priscilla A
Abstract excerpt
Loss of full-length Brca1 in mammary epithelial cells of the mouse mammary tumor virus (MMTV)-Cre Brca1 conditional exon 11 deletion mouse model results in the development of mammary adenocarcinomas with similar genetic changes to those found in human BRCA1-mutation-related breast cancers. We used this experimental model to evaluate the chemopreventive effect of tamoxifen on the development of mammary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
